The Temerty Centre for Therapeutic Brain Intervention offers clinical consultation for clients with persistent and difficult to treat mental illnesses.
The service has a clinical research focus. Treatments offered include electroconvulsive therapy (ECT), magnetic seizure therapy (MST) and repetitive transcranial magnetic stimulation (rTMS). Novel treatments, rTMS and MST, are offered primarily during participation in ongoing clinical trials.
If you are interested in participating in a clinical trial, you will receive a psychiatric consultation and then meet with a research analyst, who will describe in more details the studies available and will conduct a more detailed screening to ensure you are eligible. If you are not eligible to participate in a clinical research trial, you may or may not be able to receive treatment outside the context of a clinical trial. A referral is required.
Who can be referred?
For ECT: Severe and/or treatment-resistant psychiatric illnesses: unipolar depression, bipolar disorder, schizoaffective disorder, and schizophrenia, primarily.
For rTMS: Depression that has not responded to at least one antidepressant trial, bipolar depression, anorexia nervosa.
For MST: Unipolar depression, bipolar disorder, schizoaffective disorder, schizophrenia, and OCD.
For tDCS: Older adults with mild cognitive impairment and/or late-onset depression.
Note: Clients with active substance use disorders may not be appropriate for a brain stimulation intervention but they can still be referred for consultation.
Please have your doctor complete a CAMH Referral Form and fax it to Access CAMH, CAMH’s centralized intake. If you have any questions about the referral or intake process, please call Access CAMH.